Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2Phase 3 Interventional

Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

ClinicalTrials.gov ID: NCT01273779

Public ClinicalTrials.gov record NCT01273779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OASIS: A Phase 2/3 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study will evaluate the safety and potential benefit of talactoferrin (recombinant human lactoferrin) as an addition to the standard care for severe sepsis.

Study identification

NCT ID
NCT01273779
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Agennix
Industry
Enrollment
1,280 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2011 (Type not available)
Primary completion
Jan 2014 (Estimated)
Completion
Dec 2014 (Estimated)
Last update posted
Feb 3, 2012

2011 – 2014

United States locations

U.S. sites
34
U.S. states
26
U.S. cities
34
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35249 —
Providence Hospital Mobile Alabama 36608 —
Maricopa Medical Center Maricopa Arizona 85008 —
St. Joseph Hospital Orange California 92868 —
Sharp Memorial Hospital San Diego California 92123 —
Stanford University Hospital Stanford California 94305-5117 —
UCLA Medical Center Sylmar California 91342 —
Denver Health Medical Center Denver Colorado 80204 —
Christiana Care Health Services Newark Delaware 19718 —
George Washington University Hospital Washington D.C. District of Columbia 20037 —
Bay Area Chest Physicians Clearwater Florida 33756 —
Eastern Idaho Medical Consultants Idaho Falls Idaho 83404 —
West Suburban Hospital Medical Center Oak Park Illinois 60302 —
Peoria Pulmonary Associates Peoria Illinois 61603 —
Methodist Research Institute Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Baystate Medical Center Springfield Massachusetts 01199 —
Henry Ford Hospital Detroit Michigan 48202 —
St. Johns Mercy Medical Center St Louis Missouri 63141 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Cooper University Hospital Camden New Jersey 08103 —
Moses Cone Memorial Hospital Greensboro North Carolina 27401 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27517 —
Riverside Methodist Hospital Columbus Ohio 43214 —
St. Vincent Mercy Medical Center Toledo Ohio 43608 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
Cancer Institute, Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
Rhode Island Hospital Providence Rhode Island 02903 —
University of Tennessee Memphis Tennessee 38163 —
Texas Tech Health Science Center El Paso Texas 79905 —
Baylor College of Medicine Houston Texas 77030 —
LDS Hospital Murray Utah 84157 —
University of Wisconsin Medical School Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01273779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01273779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →